Publications of S. Kloiber
All genres
Journal Article (95)
2016
Journal Article
21 (2), pp. 277 - 289 (2016)
FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY
Journal Article
59 (2), pp. 6 - 11 (2016)
Akupunktur bei psychiatrischen Erkrankungen – Literaturüberblick und Entwicklungsmöglichkeiten Teil 2: Depressive Erkrankungen (unipolare Depression, schwangerschaftsassoziierte depressive Störungen, Poststroke Depression), Angststörungen. DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR
Journal Article
59 (3), pp. 6 - 9 (2016)
Akupunktur bei psychiatrischen Erkrankungen – Literaturüberblick und Entwicklungsmöglichkeiten Teil 3: Somatoforme Störungen, Posttraumatische Störungen, bipolare Störungen, Zwangserkrankungen, Schlafstörungen, Schizophrenie. DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR
Journal Article
59 (1), pp. 7 - 13 (2016)
Akupunktur bei psychiatrischen Erkrankungen Literaturüberblick und Entwicklungsmöglichkeiten. DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR
Journal Article
7, 10023 (2016)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. NATURE COMMUNICATIONS 2015
Journal Article
57, pp. 111 - 112 (2015)
Letter to the Editor. PSYCHONEUROENDOCRINOLOGY
Journal Article
65, pp. 166 - 171 (2015)
Poor sleep quality is associated with impaired glucose tolerance in women after gestational diabetes. JOURNAL OF PSYCHIATRIC RESEARCH
Journal Article
25 (6), pp. 864 - 872 (2015)
IGF-I in major depression and antidepressant treatment response. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
20 (6), pp. 735 - 743 (2015)
The association between lower educational attainment and depression owing to shared genetic effects? Results in similar to 25 000 subjects. MOLECULAR PSYCHIATRY
Journal Article
13, 86 (2015)
A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder. BMC MEDICINE
Journal Article
10 (3), e0119752 (2015)
Modulation of Genetic Associations with Serum Urate Levels by Body-Mass-Index in Humans. PLOS ONE
Journal Article
8 (404), p. ra119 - ra119 (2015)
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Science signaling
Journal Article
76 (6), pp. e802 - e808 (2015)
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. The Journal of clinical psychiatry 2014
Journal Article
11 (11), e1001755 (2014)
Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans. PLOS MEDICINE
Journal Article
49, pp. 229 - 243 (2014)
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach. PSYCHONEUROENDOCRINOLOGY
Journal Article
76 (7), pp. E15 - E17 (2014)
Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response. BIOLOGICAL PSYCHIATRY
Journal Article
4, e352 (2014)
Plasma fibrinogen: now also an antidepressant response marker? TRANSLATIONAL PSYCHIATRY 2013
Journal Article
23 (11), pp. 1503 - 1515 (2013)
Prediction of antidepressant treatment response from gray matter volume across diagnostic categories. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
23 (7), pp. 653 - 662 (2013)
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
36 (5), pp. 661 - 669 (2013)
Mirtazapine Provokes Periodic Leg Movements during Sleep in Young Healthy Men. SLEEP